Optimizing risk management for post-amputation wound complications in diabetic patients: Focus on glycemic and immunosuppressive control

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

Figures (1-1)

Tables (1-2)

Sum=80

Publishing Process of This Article

Item

Count

Browse

Download

Sum=3

Mar 15, 2025 (publication date) through Jan 23, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Letter to the Editor

World J Diabetes. Mar 15, 2025; 16(3): 102899
Published online Mar 15, 2025. doi: 10.4239/wjd.v16.i3.102899

Figure 1 Distribution ratio of risk factors in wound complication group. HbA1c: Hemoglobin A1c.

Citation: Li ZP, Sun JK, Fu WP, Zhang CJ. Optimizing risk management for post-amputation wound complications in diabetic patients: Focus on glycemic and immunosuppressive control. World J Diabetes 2025; 16(3): 102899
URL: https://www.wjgnet.com/1948-9358/full/v16/i3/102899.htm
DOI: https://dx.doi.org/10.4239/wjd.v16.i3.102899